SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000902664-17-003660
Filing Date
2017-09-19
Accepted
2017-09-19 06:00:51
Documents
1
Period of Report
2017-09-15

Document Format Files

Seq Description Document Type Size
1 MIRATI THERAPEUTICS, INC. p17-1889form3.html 3  
1 MIRATI THERAPEUTICS, INC. p17-1889form3.xml 3 5973
  Complete submission text file 0000902664-17-003660.txt   7974
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 120 WEST 45TH STREET SUITE 2802 NEW YORK NY 10036
Business Address 120 WEST 45TH STREET SUITE 2802 NEW YORK NY 10036 212-937-4975
venBio Select Advisor LLC (Reporting) CIK: 0001633313 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 171091031

Mailing Address C/O VENBIO SELECT ADVISOR LLC 120 W. 45TH STREET, 28TH FLOOR NEW YORK NY 10036
Business Address
Aghazadeh Behzad (Reporting) CIK: 0001701815 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 171091030